将芳香疗法与五草精油对PCPA诱导的失眠小鼠的影响进行比较
Peipei Feng1, Jingyi Chen1, Xiaolu Chen1
1Guangdong He Ji Biotech Co., Ltd., Guangzhou 510000, P.R. China.
Journal of microbiology and biotechnology
|January 23, 2025
概括
使用五种植物精油 (EO) 的芳香疗法有效地改善了小鼠的睡眠,这些小鼠患有偏乙烯氨酸 (PCPA) 诱导的失眠症. 这些EO调节了神经递质受体表达,为睡眠障碍提供了潜在的自然治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 延迟治疗失眠会对身体和心理健康产生负面影响.
- 芳香疗法提供了一种补充方法来管理失眠及其副作用.
- 来自特定植物的精油 (EO) 显示出潜在的治疗益处.
研究的目的:
- 为了研究五种植物EO对对小鼠的甲甲氨酸 (PCPA) 诱导的失眠的诱导效应.
- 确定EO中的活性成分,并评估它们对生理和神经标志物的影响.
- 评估芳香疗法在治疗失眠方面的治疗潜力.
主要方法:
- 在昆明小鼠中建立了PCPA诱导的失眠模型.
- 芳香疗法使用来自 *Jasminum sambac*, *Magnolia denudata*, *Rosa rugosa*, *Aloysia citriodora* 和 *Abies balsamea* 的精油进行.
- 评估体重变化,睡眠延迟,总睡眠时间,血清指数,神经元形态 (尼斯尔染色) 和神经递质受体表达 (5-HT1A,GABAARα1) 通过免疫组织化学,西部涂抹和RT-qPCR.
- 气色谱-质谱 (GC-MS) 用于EO组件的识别.
主要成果:
- 这五种EO含有丰富的类物质,如α-farnesene,linalol和citronellol,对失眠相关的体重减轻产生了不同的影响.
- 与PCPA模型相比,Nissl染色显示EO治疗组的神经元数量增加,除了Rosa rugosaEO外.
- 所有经过测试的EO都提高了5-HT1A和GABAARα1.1的表达.
- *Aloysia citriodora* 和 *Abies balsamea* EO显著提高了5-HT1A蛋白表达的调节.
结论:
- 研究中的精油在失眠的小鼠模型中具有促进睡眠的特性.
- 使用这些EO的芳香疗法调节关键的神经递质系统 (血清和GABAergic) 参与睡眠调节.
- 这些发现支持使用芳香疗法作为潜在的补充治疗失眠.
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:14CNS Depressants: Barbiturates and Benzodiazepines
216
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
216